Lepota Inc. (LEPX) financial statements (2021 and earlier)
Company profile
| Business Address |
5348 VEGAS DR. LAS VEGAS, NV 89108 |
| State of Incorp. | NV |
| Fiscal Year End | July 31 |
| SIC | 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 1/31/2020 TTM | 7/31/2019 | 7/31/2018 | 7/31/2017 | 7/31/2016 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 0 | 2 | 1 | 8 | 4 | ||
| Cash and cash equivalents | 0 | 2 | 1 | 8 | 4 | ||
| Deferred costs | 6 | ||||||
| Disposal group, including discontinued operation | 1 | 2 | |||||
| Other undisclosed current assets | (1) | (2) | (6) | ||||
| Total current assets: | 0 | 2 | 1 | 8 | 4 | ||
| Noncurrent Assets | |||||||
| Other undisclosed noncurrent assets | 2 | ||||||
| Total noncurrent assets: | 2 | ||||||
| TOTAL ASSETS: | 0 | 5 | 1 | 8 | 4 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 4 | 4 | 7 | ||||
| Accrued liabilities | 3 | ||||||
| Employee-related liabilities | 4 | 4 | 4 | ||||
| Debt | 11 | 5 | 5 | ||||
| Other undisclosed current liabilities | (7) | ||||||
| Total current liabilities: | 15 | 2 | 12 | ||||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 5 | 6 | |||||
| Long-term debt, excluding current maturities | 5 | 6 | |||||
| Liabilities, other than long-term debt | 4 | 6 | |||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 2 | |||
| Due to related parties | 4 | 4 | |||||
| Other undisclosed noncurrent liabilities | (30) | 7 | (23) | ||||
| Total noncurrent liabilities: | (30) | 7 | (23) | 10 | 12 | ||
| Total liabilities: | (15) | 10 | (11) | 10 | 12 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent, including: | (15) | (7) | (11) | (2) | (7) | ||
| Common stock | 6 | 5 | |||||
| Additional paid in capital | 22 | 22 | 10 | 9 | 3 | ||
| Accumulated deficit | (44) | (37) | (27) | (17) | (15) | ||
| Receivable from shareholders or affiliates for issuance of capital stock | 1 | ||||||
| Other undisclosed stockholders' equity attributable to parent | 7 | 7 | 6 | ||||
| Other undisclosed stockholders' equity | 30 | (9) | 23 | (1) | |||
| Total stockholders' equity: | 15 | (17) | 12 | (2) | (8) | ||
| TOTAL LIABILITIES AND EQUITY: | 0 | (7) | 1 | 8 | 4 | ||
Income statement (P&L) ($ in thousands)
| 1/31/2020 TTM | 7/31/2019 | 7/31/2018 | 7/31/2017 | 7/31/2016 | ||
|---|---|---|---|---|---|---|
| Revenue, net | ✕ | ✕ | ✕ | 6 | 4 | |
| Gross profit: | 6 | 4 | ||||
| Operating expenses | (15) | (10) | (10) | (7) | (6) | |
| Other operating expense, net (Other Nonrecurring (Income) Expense) | (6) | |||||
| Other undisclosed operating income | 6 | |||||
| Operating loss: | (15) | (10) | (20) | (1) | (1) | |
| Loss from continuing operations before equity method investments, income taxes: | (15) | (10) | (20) | (1) | (1) | |
| Loss from equity method investments | (10) | |||||
| Loss from continuing operations: | (15) | (10) | (30) | (1) | (1) | |
| Loss from discontinued operations | (12) | (10) | (10) | |||
| Other undisclosed loss before gain (loss) on sale of properties | (10) | |||||
| Loss before gain (loss) on sale of properties: | (37) | (20) | (40) | (1) | (1) | |
| Other undisclosed net income | 19 | 10 | ||||
| Net loss: | (17) | (10) | (40) | (1) | (1) | |
| Other undisclosed net income attributable to parent | 3 | |||||
| Net loss available to common stockholders, diluted: | (15) | (10) | (40) | (1) | (1) | |
Comprehensive Income ($ in thousands)
| 1/31/2020 TTM | 7/31/2019 | 7/31/2018 | 7/31/2017 | 7/31/2016 | ||
|---|---|---|---|---|---|---|
| Net loss: | (17) | (10) | (40) | (1) | (1) | |
| Comprehensive loss, net of tax, attributable to parent: | (17) | (10) | (40) | (1) | (1) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.